Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market : Global Industry Analysis and Forecast (2023-2029)

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market is expected to reach US$ 5.15 Bn. at a CAGR of 5.43 %  during the forecast period 2029. The Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market report also provides trends by market segments, technology, and investment with a competitive landscape. Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market To know about the Research Methodology :- Request Free Sample Report

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Overview:

ELISA stands for Enzyme-Linked Immunosorbent Assay. This test is used in laboratory tests to identify antibodies in the blood samples. Antibodies are proteins produced by the body's immune system when it detects harmful substances, called antigens.

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Dynamics:

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market is estimated to grow at a CAGR of 8.3% in the forecast period of 2020-2026. The Enzyme-Linked Immunosorbent Assay (ELISA) testing market is anticipated to gain more attraction in the forecast period due to the occurrence of infectious diseases like hepatitis, dengue, hepatitis, AIDS, Cancer, and neurological disorders. Moreover, the growing population and demand for cost-effective diagnosis are further motivating the market growth of the Enzyme-Linked Immunosorbent Assay (ELISA) testing market in the forecast period 2023-2029. Further, the arrival of the latest technologies and developments in cost-effective technologies with effective results are the major factors boosting the demand for the Enzyme-Linked Immunosorbent Assay (ELISA) testing market. Moreover, ELISA has few advantages like Simple procedure, High specificity, and sensitivity, due to an antigen-antibody reaction and this makes it more favorable in the market. Stringent rules and regulations imposed by the government and the healthcare ministry are likely to challenge the market growth as the innovation in the medical sector need approval from the healthcare ministries and this process is time-consuming.

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Segment Analysis:

Sandwich ELISA is dominating the type segment of Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market:

A sandwich ELISA is used in measuring antigen between two layers of antibodies (capture and detection antibody). The target antigens have two antigenic sites accomplished for binding to the antibodies. Monoclonal or polyclonal antibodies are used for capturing and recognizing antibodies in sandwich ELISA systems. Sandwich ELISA is best for the detection of immunological response and this factor is supporting the growth of the market. Moreover, Sandwich ELISA is the most sensitive test among all with high flexibility and increased specificity, as various antibodies bind to the same antigen for recognition or detection. The Advantage of Sandwich ELISA is that the sample does not have to purify before analysis. And this factor drives the market growth of the Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market.

Infectious diseases are trending in the application segment of the Enzyme-Linked Immunosorbent Assay (ELISA) testing market.

Infectious Diseases are dominating the application segment of the ELISA market due to rising incidents of chronic diseases and infectious diseases. Infectious blood-borne diseases like HIV, HBV, HCV, HTLV, Diphtheria, Giardiasis, and various others. As ELISA tests offer quick and accurate results, high sensitivity, automated and simple to perform, and do not need radioactive substances or costly radiation apparatus and this factor dominates the application segment of the Enzyme-Linked Immunosorbent Assay (ELISA) testing market. In addition, rapid advances in the technology and the detection parameters, and cost-effective testing is further boosting the market growth of the application segment in the forecast period of 2023-2029.

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Regional Insights:

North America is dominating the Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market in the regional segment due to rapid advances in healthcare infrastructure and facilities. In addition, the penetration of technology with high-end medical services and devices is further fueling the growth of North America in the Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market in the regional segment. Further, the economy of the country and the purchasing power of the individual is anticipated to boost the demand for ELISA testing due to accuracy and high sensitivity testing as these tests are expensive. The Asia Pacific is second dominating in the Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market regional segment due to high expenditure in healthcare infrastructure by the government. Moreover, the adoption of medical devices to offer better healthcare services to individuals is further motivating the market flow. The dominating countries of Asia Pacific are China, Japan, Australia, India, and Indonesia. The objective of the report is to present a comprehensive analysis of the Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market dynamics, structure by analyzing the market segments and project the Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market make the report investor’s guide.

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Scope: Inquire before buying

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2017 to 2022 Market Size in 2022: US $ 3.56 Bn.
Forecast Period 2023 to 2029 CAGR: 5.43 % Market Size in 2029: US $ 5.15 Bn.
Segments Covered: by Type • Sandwich ELISA • Indirect ELISA • Multiple and portable ELISA • Competitive ELISA
by Application • Immunology • Inflammation • Infectious diseases • Cancer • Protein quantitation • Others

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, by Region

North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)

Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Key Player

Ortho-Clinical Diagnostics, Inc. • Thermo Fisher Scientific. Inc. • Life Technologies Corporation • ZEUS Scientific, Inc. • Abcam Plc • Agilent Technologies Inc. • Becton • Dickinson and Co. • bioMérieux SA • Bio-Rad Laboratories Inc. • F. Hoffmann-La Roche Ltd. • Merck KGaA • PerkinElmer Inc. • QIAGEN NV • RayBiotech, Inc. • R&D Systems, Inc., • Arbor Assays • ALPCO Frequently Asked Questions: 1. Which region has the largest share in Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market? Ans: The Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market is growing at a CAGR of 5.43 % during forecasting period 2023-2029. 3. What is scope of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market report? Ans: Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market? Ans: The important key players in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market are – Ortho-Clinical Diagnostics, Inc.,Thermo Fisher Scientific. Inc.,Life Technologies Corporation,ZEUS Scientific, Inc.,Abcam Plc,Agilent Technologies Inc.,Becton,Dickinson and Co.,bioMérieux SA,Bio-Rad Laboratories Inc.,F. Hoffmann-La Roche Ltd.,Merck KGaA,PerkinElmer Inc.,QIAGEN NV,RayBiotech, Inc.,R&D Systems, Inc.,,Arbor Assays,ALPCO 5. What is the study period of this Market? Ans: The Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market 3.4. Geographical Snapshot of the Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market, By Manufacturer share 4. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market 5. Supply Side and Demand Side Indicators 6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecast, 2022-2029 6.1. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size & Y-o-Y Growth Analysis. 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 7.1.1. Sandwich ELISA 7.1.2. Indirect ELISA 7.1.3. Multiple and portable ELISA 7.1.4. Competitive ELISA 7.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 7.2.1. Immunology 7.2.2. Inflammation 7.2.3. Infectious diseases 7.2.4. Cancer 7.2.5. Protein quantitation 7.2.6. Others 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Type, 2022-2029 9.1.1. Sandwich ELISA 9.1.2. Indirect ELISA 9.1.3. Multiple and portable ELISA 9.1.4. Competitive ELISA 9.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 9.2.1. Immunology 9.2.2. Inflammation 9.2.3. Infectious diseases 9.2.4. Cancer 9.2.5. Protein quantitation 9.2.6. Others 10. North America Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 12. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 13. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 14. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 15. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 17. France Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 18. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 19. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 20. Spain Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 21. Sweden Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 22. CIS Countries Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 23. Rest of Europe Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 24. Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 25. Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 27. India Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 28. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 29. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 30. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 31. ASEAN Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 32. Rest of Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 33. Middle East Africa Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 34. Middle East Africa Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 36. GCC Countries Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 37. Egypt Textile Reinforced Concrete e Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 38. Nigeria Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 39. Rest of ME&A Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 40. South America Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 41. South America Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 43. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 44. Rest of South America Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. ALPCO 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Development 45.3.2. Ortho-Clinical Diagnostics, Inc. 45.3.3. Thermo Fisher Scientific. Inc. 45.3.4. Life Technologies Corporation 45.3.5. ZEUS Scientific, Inc. 45.3.6. Abcam Plc 45.3.7. Agilent Technologies Inc. 45.3.8. Becton 45.3.9. Dickinson and Co. 45.3.10. bioMérieux SA 45.3.11. Bio-Rad Laboratories Inc. 45.3.12. F. Hoffmann-La Roche Ltd. 45.3.13. Merck KGaA 45.3.14. PerkinElmer Inc. 45.3.15. QIAGEN NV 45.3.16. RayBiotech, Inc. 45.3.17. R&D Systems, Inc., 45.3.18. Arbor Assays 46. Primary Key Insights
  • INQUIRE BEFORE BUYING